Clinical Trial Update: Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating anlotinib hydrochloride capsules with penpulimab for hepatocellular carcinoma at high risk of recurrence is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)
• Penpulimab

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: RECRUITING